Is this your firm? Get featured or correct your listing →
We track Roth Principal Investments but have little verified detail yet.
Latest Pulse
- Aug 25, 2026Two More S-1s Land: Enhanced Group, Serina TherapeuticsEnhanced Group filed a new S-1 on August 25 while biotech Serina Therapeutics registered up to 12.5 million shares for sale to Roth Principal Investments, two more entries in this week's dense small-cap SEC filing pipeline.→
- Aug 24, 2026Serina Therapeutics Files to Sell Shares for Parkinson's DrugBiotech Serina Therapeutics filed an S-1 covering up to 12.5 million shares tied to a stock purchase agreement, funding continued development of its lead Parkinson's disease candidate SER-252 built on its POZ drug-delivery platform.→
- Jul 2, 2026Peraso Files S-1 for a $25M Equity Line as the mmWave Chipmaker's Stock Sits Under $1Peraso Inc., a fabless semiconductor company building millimeter-wave (mmWave) wireless chips, filed an S-1 on July 2 registering up to 31.75 million shares for resale by Roth Principal Investments under a new Common Stock Purchase Agreement dated June 30 -- an equity line that could provide Peraso up to $25 million in gross proceeds. The filing comes with shares trading at just $0.83 on the Nasdaq Capital Market as of June 29, and Peraso's auditor has flagged substantial doubt about its ability to continue as a going concern.→